Page last updated: 2024-11-04

ropinirole and Acute Ischemic Stroke

ropinirole has been researched along with Acute Ischemic Stroke in 1 studies

Research Excerpts

ExcerptRelevanceReference
" The drug's low bioavailability in brain however, limits its therapeutic efficacy."5.72Crafting ɣ-L-Glutamyl-l-Cysteine layered Human Serum Albumin-nanoconstructs for brain targeted delivery of ropinirole to attenuate cerebral ischemia/reperfusion injury via "3A approach". ( Abdin, MZ; Ahmad, FJ; Ali, M; Beg, S; Fatima, S; Mishra, P; Parvez, S; Quadri, SN; Samim, M, 2022)
" The drug's low bioavailability in brain however, limits its therapeutic efficacy."1.72Crafting ɣ-L-Glutamyl-l-Cysteine layered Human Serum Albumin-nanoconstructs for brain targeted delivery of ropinirole to attenuate cerebral ischemia/reperfusion injury via "3A approach". ( Abdin, MZ; Ahmad, FJ; Ali, M; Beg, S; Fatima, S; Mishra, P; Parvez, S; Quadri, SN; Samim, M, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fatima, S1
Ali, M1
Quadri, SN1
Beg, S1
Samim, M1
Parvez, S1
Abdin, MZ1
Mishra, P1
Ahmad, FJ1

Other Studies

1 other study available for ropinirole and Acute Ischemic Stroke

ArticleYear
Crafting ɣ-L-Glutamyl-l-Cysteine layered Human Serum Albumin-nanoconstructs for brain targeted delivery of ropinirole to attenuate cerebral ischemia/reperfusion injury via "3A approach".
    Biomaterials, 2022, Volume: 289

    Topics: Antioxidants; Brain; Brain Ischemia; Cysteine; Dopamine; Humans; Indoles; Infarction, Middle Cerebra

2022